Skip to main content
Deciphera
Deciphera Medical Affairs
  • Our Company
    • Who We Are
    • Leadership
  • Focus Areas
    • Overview
    • Oncology
    • Immunology & Inflammation
    • Neurology
  • Pipeline
    • Ongoing Clinical Trials
    • Presentations & Publications
  • Patients & Care Partners
    • Expanded Access
  • Healthcare Professionals (Coming soon!)
  • Our Medicines
  • Join Us
    • Our Culture
    • Open Positions
  • News
  • Ono Pharma

ONO-4578

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (NCT06256328)
  • Oncology
  • Disease/Condition: Gastric Cancer
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/​dMMR, PD-L1 Positive Advanced Colorectal Cancer (NCT06948448)
  • Oncology
  • Disease/Condition: Colorectal Cancer

© 2026 Deciphera Pharmaceuticals, LLC. Deciphera Pharmaceuticals, LLC, DECIPHERA, and the Deciphera logo are registered trademarks of Deciphera Pharmaceuticals.

  • Privacy Policy
  • Contact Us
  • Terms of Use
linkedin twitter
DCPH-M01057 v1 09/26
Back to top